Rare diseases
Investigational molecules
Locations
420-1111 Dr.-Frederik-Philips Boulevard, H4M 2X6
Research activity is centered on paroxysmal supraventricular tachycardia, with attention to rapid heart rhythm control in patients experiencing spontaneous episodes. The clinical focus includes treatment options for younger populations affected by episodic supraventricular tachycardia.
The sponsor’s trial activity reflects interest in managing symptomatic arrhythmia across pediatric age groups, including adolescents and children.
Milestone Pharmaceuticals Inc. runs clinical trials in conditions such as Atrial fibrillation, Supraventricular tachycardia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
The Netherlands
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
